-
Mashup Score: 1Programme Information - EANM 2023 Congress | | September 9-13, 2023 - 8 month(s) ago
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.The cookies that are categorized as “Necessary” are stored on your browser as they are essential for enabling the basic functionalities of the site. …
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Register for EACVI Congress - 1 year(s) ago
EACVI official website: Register for EACVI congress and take advantage of the best rates by registering early. Get the latest cardiovascular imaging research findings and their interpretation, in-depth science, and solid education.
Source: www.escardio.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Register for EACVI Congress - 1 year(s) ago
Your access to the latest cardiovascular news, science, tools and resources.
Source: www.escardio.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2Nuclear Physics and Therapy: Preliminary Report on a New Method for the Treatment of Leukemia and Polycythemia - 1 year(s) ago
BECAUSE of the discoveries and developments in the field of nuclear physics during the past few years, artificial radio-activity is available in nearly all of the chemical elements. Although these new radio-active isotopes give off rays (beta rays, gamma rays, positrons, etc.) similar to those emitted by radium, they differ markedly from radium in several respects. In the first place, each…
Source: RadiologyCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 2FBPA-PET can differentiate between malignant and benign lesions - 1 year(s) ago
PET/CT imaging with a boron-based radiotracer is superior to that with standard F-18 FDG for differentiating malignant from benign lesions, according to a study published December 5 in Annals of Nuclear Medicine.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0Road to RSNA 2022: Molecular Imaging Preview - 1 year(s) ago
This year’s nuclear medicine and molecular imaging program at RSNA 2022 resounds with the impact of theranostics on the lives of patients with prostate cancer, with prostate-specific membrane antigen PET imaging taking center stage. Organizers even saw fit to title one scientific session “Prostate and Theranostics Potpourri.”
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0FDG-PET predicts survival in adrenal cancer patients - 2 year(s) ago
PET scans with an F-18 FDG radiotracer may predict overall survival in patients with adrenocortical carcinoma, according to a study published September 8 in the American Journal of Surgery.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 4How low can FDG dose go on PET/MRI? - 2 year(s) ago
Researchers in France say radiation doses in PET/MRI exams can be reduced significantly without compromising image quality in patients with neurological disorders, according to a study published September 12 in Scientific Reports.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 0Is scientific fraud rife in nuclear medicine journals? - 2 year(s) ago
Scientific fraud may be a problem in nuclear medicine research journals, says a group in the Netherlands that conducted a recent global survey on the issue. Results were published September 8 in the Journal of Nuclear Medicine.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
-
Mashup Score: 1Interest in nuclear medicine research dips among residents - 2 year(s) ago
Nuclear medicine’s best bet to attract more physicians to the field may be to get its hooks into residents interested in recent clinical advances, according to a study published September 1 in Academic Radiology.
Source: AuntMinnie.comCategories: Latest Headlines, RadiologyTweet
Don't miss the joint EANM-EORTC session on #NuclearMedicine #Imaging of the #ImmuneSystem at #EANM23 in Vienna on Sunday, 10 September. https://t.co/PyhZ4W71Tf @EANM_NucMed #NucMed #CancerResearch #ClinicalTrials https://t.co/rMSuC1ai6S